| |
|
|
|
|
| |
 |
|
Click
here
to unsubscribe
Click here
to subscribe |
|
 |
|
|
|
| |
|
 |
|
|
 |
| |
Newsbank |
| |
 |
Issue
11, September 2005 |
|
| Welcome
to the Northbank newsletter |
| |
Many of you will have received the first in Northbank's
new postcard series - our "August" card celebrates
the discovery of oxygen. We have developed a series of month-based
cards that celebrate scientific discovery and invention.
Through these cards and other marketing materials, you will
see our guiding themes that we follow in everything we do
- Science I Leadership I Passion I Communication. Our core
focus is on science-based industries where entrepreneurship
and innovation underpin wealth creation. We continue to
strive to create a leadership position for ourselves, and
work with companies and organisations who, like you, are
leaders in their fields. We remain passionate about what
we do and about achieving results for our clients - we go
the extra mile to ensure that our work adds value. And everything
we do is about communication, starting with good communication
between our staff and our clients' team. This newsletter
underlines our commitment to keep you, our clients and contacts,
up-to-date.
Sue
Charles, CEO
|
|
|
| Contents |
| Support
at BIO 2005 |
| Design
work for Trigen |
| New
look for Oxford Optronix |
| Munich
office relocation |
| Arakis
instruction leaflet |
| IntegraGen’s
autism programme |
| Charity
run |
| PR
Week Awards 2005 finalists |
| Medical
Futures Awards |
| OBN
cluster report |
|
Promotions at Northbank |
| New
appointments at Northbank |
| Ablynx
in the news |
| Super
quick work for Lipoxen |
| Exam
results |
| Cross
border IR in Europe |
| In
the press |
| Event
round-up |
| New
business wins |
| Client
round-up |
| Meet
us at |
|
| In
brief |
|
Northbank
Communications has been named as a finalist in the category
"Specialist Communications Consultancy of the Year"
for the PR Week Awards 2005. Full
press release |
|
| Medical
Futures held its Innovation Awards Judging Day on 13 June where
30 short listed finalists from over 1100 entries presented their
innovations in front of a distinguished panel of 30 experts
from medicine, business and the media. Northbank supported the
day through media relations prior to and during the event to
boost coverage of the innovations and the Awards, the winners
of which will be announced on 3rd November. www.medicalfutures.co.uk |
|
Northbank
advised on a new Oxfordshire Bioscience Cluster report for
2005, which was launched on July 20th at the well-attended
Oxfordshire Bioscience Network’s summer barbeque.
More
… |
|
| Northbank
Communications has announced three promotions and a new addition
in its London team, as a result of continued client growth.
Full
press release |
|
As
a result of continued client growth, Northbank Communications
has announced an expansion with the appointment of two account
managers, Lorna Watson and Dr Christelle Kerouedan, to the
London team.
Full
press release |
|
The
August issue of Scientific American features a review of Ablynx’s
Nanobodies™ and their use as a novel class of therapeutics.
Click
here to view the on-line version of the article. |
|
Northbank
and Lipoxen were not beaten by the terrorists! When Lipoxen
Technologies needed some design and editing work turned around
at short notice, Northbank was only too happy to oblige! Not
even widespread security alerts and the need to evacuate the
office for more than an hour curbed our enthusiasm and Lipoxen
was pleased with the end result. |
|
Congratulations
to Ashley Lilly who has gained a merit in the Critical Reasoning
Test part of the Chartered Institute of PR’s Advanced
Certificate in PR.
Well done to Lorna Watson for achieving a CIM Professional
Diploma in Marketing with a distinction in Marketing Communications.
|
|
|
It seemed a good idea at the time. A gentle jog around Battersea
Park. Take in the sunshine, its only 5.6km they said. Rallying
a somewhat unsure ‘work hard, play hard’ attitude,
six members of the Northbank Team entered the JP Morgan Chase
Corporate Challenge, raising vital funds for the official charity,
SportsAid. More
... |
|
Cross
border IR in Europe
Sometimes, in a saturated market or where external
markets may offer riper investor opportunities, companies that
are listed in the US or Europe may wish to attract investors
from selected financial centres outside of their national market.
More
… |
|
| In
the press |
Don't
keep them guessing |
|
| Event
round-up |
Event
round-up
MipTec, Sozo, BIA BioBusiness Exchange, BioEquity Europe,
Biotech and Finance Forum, techMARK mediscience awards dinner,
BIO 2005, Growth Co Investor show, ESACT |
|
|
Northbank
supports clients at BIO 2005
The weeks leading up to BIO can be a stressful time for
a company as it struggles to schedule partnering meetings,
prepare marketing and exhibit materials, and create a plan
for getting the most out of this busy conference.
Northbank Communications provided crucial support and consultation
during this process for several clients including Ablynx,
Atugen, Biacore, BioInvent International, Borean Pharma,
Cobra Biomanufacturing, IntegraGen, MNLpharma, Oxford BioMedica,
Plethora Solutions, PowderMed, Santaris Pharma and Symphogen.
More
…
|
|
|
Northbank
beats the drum for Trigen
 In
April 2005, Trigen, the London-based cardiovascular drug
discovery and development company announced its merger with
Munich-based ProCorde. Following this merger, Northbank
Communications was called in to develop Trigen’s brand
identity and realign its corporate and communications materials
with the new goals and capabilities of the Company. Importantly,
the new look Trigen had to incorporate branding elements
of each company pre-merger and reflect the new entity. The
new-look Trigen was rolled out to key audiences at the International
Society on Thrombosis & Haemostasis (ISTH) conference
held in Sydney in August 2005. More
…
|
|
|
Oxford
Optronix takes new look to the web
and beyond
Having created a fresh, modern corporate identity that better
fits Oxford Optronix’ current position, messages and
values, Northbank has produced its most readily accessible
marketing tool, the website. Utilising the modern colour
palette and a visual style combining photography and illustration,
the website provides a sales tool for the Company’s
range of tissue monitoring and automated mammalian cell
colony counting instruments – together with the Company’s
range of sensors and available add-on’s. More
…
|
|
|
 Northbank
appoints Douglas Pretsell PhD as Munich Bureau Chief and
moves to larger offices in Munich
Northbank is pleased to announce that it has reinforced
its presence in Central Europe with a move to new offices
in Munich. Dr Douglas Pretsell, Senior Account Manager,
has taken up the post of Munich Bureau Chief and will continue
to drive Northbank’s European life science and biotech
business from Germany. More
...
|
|
|
IntegraGen
identifies a key brain protein involved
in autism
Scientists at IntegraGen, the personalised medicine company,
published the results of a genetic linkage analysis showing
a strong association between the protein PRKCB1 and autism
in the August issue of the journal Molecular Psychiatry.
Northbank worked with IntegraGen to publicise this development
through the media by drafting, distributing and pitching
a press release to science writers.
More
…
|
|
|
Arakis
looks to Northbank for clinical trials instructions leaflet
High profile Arakis, prior to being acquired by Sosei, approached
Northbank to design and produce an instruction leaflet as
part of a clinical trials study involving a capsule-based
inhaled delivery system.
As with all instruction leaflets, clear communication of
information is imperative and the regulations and procedures
surrounding clinical trials heighten this. A simple illustration
style was decided upon to guide the subject through the
procedure, which also circumvented any unintended association
with a specific gender or ethnic background. More...
|
|
|
Events
we are supporting
Northbank
works closely with many conferences, providing a variety
of PR, marketing support and sponsorship. For some events
we have been able to negotiate discounted rates for
our clients and contacts - see below |
| |
|
The
i2 Event, 1 October 2005, London, UK
One day event for healthcare professionals
and small healthcare businesses wishing to
develop and commercialise their ideas, innovations
and business propositions. There are two streams,
one for ideas people and one for entrepreneurs.
|
|
Sachs
Biotech in Europe Investor Forum, 4 –
5 October 2005, Zurich, Switzerland
Presentations from start-up to pre-IPO biotech/medtech
companies, listed companies, market and key
sector overviews. An audience of over 450
investors, pharmas, fund managers and capital
raising companies provides prime executive-level
networking and deal making opportunities.
If you are a Northbank client and you are
not already signed up to present, click
here to receive a 10% discount on the
presenting fee. |
|
Universities
of Bath, Bristol, Southampton & Surrey's
Second Investor Showcase, 20 Oct, London,
UK
An opportunity to see 16 of the most exciting
spin-out and start-up new technology ventures
exhibiting from the Universities’ SETsquared
Partnership. Three out of the six presenting
companies are life sciences focused with more
life science companies exhibiting. Their backgrounds
include oncology, infectious diseases, medical
devices and drug discovery. Strictly investor
and media invitation only. Please click
here to request an invitation. |
| |
Bio-Europe
2005 7 – 9 November, 2005, Dresden,
Germany
Europe's largest and most successful partnering
conference. International decision makers
in the biotechnology, pharmaceutical and financial
sector can meet through pre-partnering sessions. |
|
Sachs
London Biotech Investor Forum, 12 December
2005, London, UK
A one day forum exclusively focused on the
most promising public and private companies
in the biotechnology industry. The event will
feature 40 company presentations and talks
by leading speakers from the investment banking,
money management and VC community. If you
are a Northbank client and you are not already
signed up to present, click
here to receive a 10% discount on the
presenting fee. |
|
|
|
|
|
| New
business wins |
| |
| Since
May 2005, Northbank has … won messaging consultancy
projects for Akos Healthcare, Evotec
Technologies, Oxford Genome Sciences
and Oxitec… won copywriting consultancy
projects for Alliance Pharma and Basilea
Pharmaceutica … secured Borean Pharma
and SR Pharma as retainer clients …
extended its involvement with Neurotech to
web copywriting … won a copywriting project for Amaxa
BioSystems … been appointed PR consultants
and launch managers for BioKnex … won
PR projects for Cerenis Therapeutics, LifeCycle
Pharma and Lipoxen Technologies
… been retained for PR and IR by Plant Impact
… won design projects for Genomic Solutions,
Physiomics, Plethora, Symphogen
and Syngenta BioPharma … secured website
design and copywriting projects for MNLpharma,
Oxagen and Physiomics …
been appointed web manager for Serotec …
won corporate image, web design and corporate materials design
for Trigen and ProtAffin
… secured brand development and integration projects
for Peakdale Molecular. |
|
|
| Client
round-up |
| |
| Since
May 2005, Northbank has … managed PR outreach for
IntegraGen in its Autism programme and PowderMed
in its flu programme … provided support and consultation
at BIO 2005 for Ablynx, Atugen,
Biacore, BioInvent International,
Borean Pharma, Cobra Biomanufacturing,
IntegraGen, MNLpharma, Oxford
BioMedica, Plethora Solutions, PowderMed,
Santaris Pharma and Symphogen
… organised a media briefing day for The SETsquared
Partnership … updated factsheets and website
for Oxford BioMedica … placed articles
in the press for Ablynx, Genomic
Solutions, MNLpharma, Oxford
BioMedica, Peakdale Molecular, Sigma-Aldrich
and West Pharmaceutical Services …
secured a CEO profile for York Pharma in
The Daily Telegraph … implemented financial PR campaigns
around developments at CeNeS Pharmaceuticals,
Physiomics, SR Pharma and
York Pharma … designed product facia
for Oxford Optronix … created product
advertising for Genomic Solutions …
produced instruction leaflets for Arakis
… secured company profiles in BioCentury for IntegraGen,
Oxford Immunotec and Santaris …
created online advertising and produced new marketing literature
and identity for Peakdale Molecular …
continued to support the advertising campaign for Biacore
… designed a direct marketing email for Serotec. |
|
|
Meet
us at |
| |
| In the
months ahead members of the Northbank team are planning to attend
the following events. Just click on the attendee if you would
like to fix up a meeting with us. Please visit
our website for updated information on events we will be
attending throughout the year. |
| |
| Event |
Date |
Location |
Attendees |
| SBS |
11
Sep - 15 Sep 2005 |
Geneva |
Lorna
Watson |
| EPIC:
European Partnering & Investment Conference |
13
Sep 2005 |
London |
Sue
Charles, Katja
Stout |
| PABORD |
14
- 15 Sep 2005 |
London |
Peter
Colley |
| OBN
Local Biotechnology Forum 5 |
27
Sep 2005 |
Abingdon |
Sarah
Jeffery |
| The
i2 Event |
1
Oct 2005 |
London |
Sue
Charles |
| Biotech
in Europe Investor Forum |
4
- 5 Oct 2005 |
Zurich |
Douglas
Pretsell |
| 13th
Annual BioPartnering Europe |
9
- 11 Oct 2005 |
London |
Sue
Charles, Katja
Stout, Adam
Michael |
| Cordia
2005 |
11
- 13 Oct 2005 |
London |
Peter
Colley |
| OBN
Communications Networking Event |
26
Oct 2005 |
Oxfordshire |
Sarah
Jeffery |
| BIO-Europe
2005 |
7
- 9 Nov 2005 |
Dresden,
Germany |
Adam
Michael, Sue
Charles, Marc
Egelhofer, Christelle
Kerouedan |
| International
Biotech and Lab Automation Europe |
15
- 16 Nov 2005 |
London |
Peter
Colley |
| OBN
monthly event |
16
Nov 2005 |
Oxfordshire |
Sarah
Jeffery |
| Medica |
16
- 19 Nov 2005 |
Düsseldorf |
Peter
Colley |
| Genesis
2005 |
1
Dec 2005 |
London |
Sue
Charles, Ashley
Lilly |
| Sachs
London Biotech Investor Forum |
12
Dec 2005 |
London |
Emma
Palmer, Sue
Charles, Rowan
Minnion |
| OBN
Christmas Party |
14
Dec 2005 |
Oxfordshire |
Sarah
Jeffery |
|
|
|
|
| |
